1. Home
  2. ICCC vs BHIL Comparison

ICCC vs BHIL Comparison

Compare ICCC & BHIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • BHIL
  • Stock Information
  • Founded
  • ICCC 1982
  • BHIL 2012
  • Country
  • ICCC United States
  • BHIL United States
  • Employees
  • ICCC N/A
  • BHIL N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • BHIL Packaged Foods
  • Sector
  • ICCC Health Care
  • BHIL Consumer Staples
  • Exchange
  • ICCC Nasdaq
  • BHIL Nasdaq
  • Market Cap
  • ICCC 28.0M
  • BHIL 27.1M
  • IPO Year
  • ICCC 1987
  • BHIL N/A
  • Fundamental
  • Price
  • ICCC $3.66
  • BHIL $4.08
  • Analyst Decision
  • ICCC
  • BHIL
  • Analyst Count
  • ICCC 0
  • BHIL 0
  • Target Price
  • ICCC N/A
  • BHIL N/A
  • AVG Volume (30 Days)
  • ICCC 14.5K
  • BHIL 13.6K
  • Earning Date
  • ICCC 11-13-2024
  • BHIL 11-12-2024
  • Dividend Yield
  • ICCC N/A
  • BHIL N/A
  • EPS Growth
  • ICCC N/A
  • BHIL N/A
  • EPS
  • ICCC N/A
  • BHIL N/A
  • Revenue
  • ICCC $23,838,002.00
  • BHIL $466,725,000.00
  • Revenue This Year
  • ICCC N/A
  • BHIL N/A
  • Revenue Next Year
  • ICCC N/A
  • BHIL N/A
  • P/E Ratio
  • ICCC N/A
  • BHIL N/A
  • Revenue Growth
  • ICCC 46.37
  • BHIL 139.60
  • 52 Week Low
  • ICCC $3.34
  • BHIL $4.11
  • 52 Week High
  • ICCC $5.59
  • BHIL $11.03
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 54.28
  • BHIL 13.19
  • Support Level
  • ICCC $3.40
  • BHIL $5.26
  • Resistance Level
  • ICCC $3.64
  • BHIL $7.45
  • Average True Range (ATR)
  • ICCC 0.16
  • BHIL 0.41
  • MACD
  • ICCC 0.01
  • BHIL -0.28
  • Stochastic Oscillator
  • ICCC 65.12
  • BHIL 0.00

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About BHIL Benson Hill Inc.

Benson Hill Inc is an ag-tech company specializing in soy protein innovation. The company has one business segment Ingredient. The company focuses on seed innovation through proprietary germplasm and the CropOS platform. This platform integrates protein, genomic, and strategic data for predictive breeding using AI and ML. They operate a Crop Accelerator for rapid prototyping. Benson Hill is developing a seed portfolio for protein ingredients, aquaculture, specialty animal feed, and vegetable oils. The company's revenue can be disaggregated into product categories: Proprietary and Non-Proprietary. Proprietary revenue is defined as any sale of a proprietary bean. Non-Proprietary revenue is all other revenue from non-Proprietary sources.

Share on Social Networks: